All News

Findings from a new study have shown that sales of sweetened drinks fell by 38% after Philadelphia implemented a tax on sugary beverages.

A California jury found that the weed killer, Roundup, caused a couple's cancer and awarded $2 billion in damages; a federal appeals court will decide if and how states could end federal Medicaid funding for Planned Parenthood; Maryland Governor Larry Hogan signs a new law raising the age for nicotine-related product purchases from 18 to 21.

Damage to mitochondria, which can occur from exposure to cigarette smoke and environmental pollutants, leads to a surge in the creation of osteoclasts that break down bone.

As pharmaceutical manufacturers and pharmacy benefit managers point fingers over who is responsible for high drug prices, employers have the opportunity to demand change to business as usual, consultant Chris Robbins of Arxcel says.

Several generic drug manufacturers are accused of price-fixing in a lawsuit; the state of Washington offers residents a universally available public option for health insurance; bills proposed by states to limit vaccine exemptions have stalled.

Even though Northwestern Medicine is projected to sustain a loss in the new Bundled Payments for Care Improvement Advanced, it plans to participate because doing so will position Northwestern Medicine as best possible to manage future challenges in episodes of care.

Adults with relapsing multiple sclerosis (MS) who are treated with ozanimod have less gray matter volume loss than patients treated with interferon, according to a post hoc analysis from the phase 3 RADIANCE Part B trial. The research was presented at the 2019 American Academy of Neurology Annual Meeting.

As National Nurses' week comes to a close, more attention needs to be brought to increasing rates of violence against employees in the field of healthcare.

Intranasal insulin treatment may have the potential to improve motor functions and verbal fluency in patients with Parkinson disease.

Researchers have identified a new target in the mitochondria of cancer cells that indicate the potential of a treatment class for certain blood cancers.

A recent study assessed patients’ preferred route of administering biologic drugs for severe asthma, as well as their related beliefs and preferences. The authors said convenience and efficacy beliefs about pharmaceuticals are important for physicians to understand in order to share decision making with patients.

Mental health disorders are rising in prevalence around the world and will cost the global economy $16 trillion by 2030. Here are 5 things about mental health during Mental Health Month this May.

Video telehealth pulmonary rehabilitation intervention reduced the risk of 30-day readmission in patients with chronic obstructive pulmonary disease.

HHS has announced that Gilead will donate its pre-exposure prophylaxis (PrEP) pill Truvada for up to 200,000 people in a multiyear agreement, just a day after the pharma giant announced that a generic version of the pill will come to market a year early. However, some activists are skeptic.

Bryan Chiang's concept lets a user take a photo of the eye using a special adapter on the smartphone; the image is then analyzed to predict blood glucose levels.

Proof-of-concept studies suggest the treatment that targets CD47 produces a strong response in patients with diffuse large B-cell lymphoma (DLBCL) with fewer adverse effects than current options.

This week, the top managed care news included HHS announcing a finalized rule requiring the disclosure of drug prices in television ads; a report finding high satisfaction with employer health coverage despite the cost; a study finding heart failure is surging among young adults.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

White patients are significantly more likely to be prescribed buprenorphine compared with patients of other races/ethnicities; Trump has backed a Florida proposal to import drugs from Canada; nearly 25% of medications approved in 2018 cost more than $30,000 per year.

Between 2004 and 2017, the annual number of fall-related fractures from walking leashed dogs increased from 1671 to 4396 among adults aged 65 years or older.

During an oral presentation of abstracts at the American Academy of Neurology’s 2019 Annual Meeting in Philadelphia, Pennsylvania, held May 4-10, researchers presented findings that suggest that while pregnant women with multiple sclerosis (MS) are often viewed as high-risk by their physician, pregnancy did not seem to increase the risk of adverse obstetrical outcomes for patients nor their babies.

During the American Thoracic Society’s Annual Meeting in Dallas, Texas, taking place May 17-22, 2019, researchers will present findings from a study investigating pirfenidone (Esbriet) in the treatment of idiopathic pulmonary fibrosis (IPF) in a real-world setting.

The FDA has approved amifampridine (Ruzurgi), the first treatment for pediatric patients with Lambert-Eaton myasthenic syndrome.

According to a recent study, hypoxia associated with episodes of upper airway obstruction in patients with obstructive sleep apnea syndrome may increase the levels of α‐synuclein in the blood and thus may contribute to the development of Parkinson disease.

President Trump today outlined a plan to tackle surprise medical billing and voiced his commitment to holding insurance companies and hospitals accountable.

Hospital prices of privately insured patients are more than twice the price that Medicare pays, according to a new report from RAND and supported by the Robert Wood Johnson Foundation, the National Institute for Health Care Reform, the Health Foundation of Greater Indianapolis, and participating employers.

Tennessee is set to become the first state to transition its Medicaid program to a block grant; a federal judge has blocked cuts to Medicare rates for 340B hospitals but did not grant permanent injunction; Senator Elizabeth Warren has unviled a plan to combat the opioid epidemic that would spend $100 billion over 10 years.

The number of patients requiring first-line chemotherapy is expected to increase by more than 50% from 2018 to 2040, and in order to deliver optimal treatment, a significant increase in the chemotherapy workforce is needed.